Therapeutic strategies for CHF in the 1990s.
The ideal therapeutic strategy would be to reverse the underlying cause of cardiac dysfunction, such as hypertension or valvular disease, while removing or minimizing those concurrent conditions or factors that tend to exacerbate symptoms. For most patients, vasodilator therapy has been shown to reduce mortality in moderate to advanced CHF.
Smith
T W
TW
Harvard University.
Kelly
R A
RA
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D002316:Cardiotonic Agents / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000009:adverse effects / Q000627:therapeutic use; D004232:Diuretics / Q000009:adverse effects / Q000627:therapeutic use; D004351:Drug Resistance; D006333:Heart Failure / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D002316:Cardiotonic Agents; D004071:Digitalis Glycosides; D004232:Diuretics; D014665:Vasodilator Agents